V-PET - A New Innovation


slide9 V-PET replaces the previous C-PET and E-PET products with a combined and improved product that can be used on both companion animal and equine patients.

V-PET is a platelet therapy modality that can be used in the treatment of osteoarthritis, damaged and poorly vascularised tissues (e.g. tendons, ligaments and cartilage) that usually do not heal or only very slowly, and often with scar tissue formation resulting in chronic pain and reduced range of motion.


Advantages of V-PET

  1. New cutting edge science – EXCLUSIVE ONLY to Veterinary Surgeons
  2. Fraction of the cost of stem cell therapy
  3. Affordable for non-insured clients
  4. Proven scientifically to have significant effect on OA and rehabilitation (JAVMA Nov. 2013)
  5. Able to manage osteoarthritic lameness for at least one year from single injection into joint
  6. Can be used as part of rehabilitation package post fracture-joint surgery
  7. 30 minutes for whole procedure
  8. Easy to perform in the operating theatre

V-PET's patented filtration system gravitationally separates out the patient’s autologous platelets from its own blood and provides a rapid, sterile, concentrated platelet sample for injection into the damaged tissues. The selective use of platelet concentrate supports in a natural way the body’s regeneration and promotes long-term pain relief and mobility, though the release of the platelets’ natural anti-inflammatories, growth factors, cell differentiators and stem cell attractants.

Platelets contain various growth factors that accelerate wound healing and promote tissue regeneration:

  • Proliferation of various cell types and differentiation (Stem cells, osteoblasts, chondroblasts, epidermal cells, etc.)
  • Increase production while inhibiting of the degradation of collagen fibres and proteoglycans
  • Increase angiogenesis
  • Reduction of inflammation by changing the balance of inflammatory molecules towards anti-inflammatory cytokines (including IL-4, IL-10, IL-1ra)

The selective use of platelet concentrate, which is obtained from the patient’s blood, supports in a natural way the body’s regeneration and promotes long-term pain relief and mobility, through release of PDGF, TGF-ß, IGF, EGF, FGF, PDEGF, PDAF into the recipient tissue.

Pall Corporation

Pall is a global leader for more than 60 years in entrepreneurship, innovation and reliability. Pall technologies accompany us in daily life: whether in aeronautical engineering, microelectronics, biotechnology or medicine, Pall filtration systems guarantee the highest quality.

In animal and human medicine Pall offer a whole new era in therapy options:

  • Regenerative therapies for the treatment of tendon, ligament and joint injuries
  • Manufacture artificial biological tissues from stem cells, e.g. for the treatment of cardiac and vascular defects
  • Filter systems for the protection of the patient during anesthesia, infusion and injection